200 related articles for article (PubMed ID: 22531648)
1. Validation of electronic data on chemotherapy and hormone therapy use in HMOs.
Ritzwoller DP; Carroll N; Delate T; O'Keeffe-Rossetti M; Fishman PA; Loggers ET; Aiello Bowles EJ; Elston-Lafata J; Hornbrook MC
Med Care; 2013 Oct; 51(10):e67-73. PubMed ID: 22531648
[TBL] [Abstract][Full Text] [Related]
2. Comparison of SEER Treatment Data With Medicare Claims.
Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL
Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121
[TBL] [Abstract][Full Text] [Related]
3. Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.
Onukwugha E; Yong C; Hussain A; Seal B; Mullins CD
BMC Med Res Methodol; 2014 Jan; 14():1. PubMed ID: 24383436
[TBL] [Abstract][Full Text] [Related]
4. Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts.
Hassett MJ; Ritzwoller DP; Taback N; Carroll N; Cronin AM; Ting GV; Schrag D; Warren JL; Hornbrook MC; Weeks JC
Med Care; 2014 Oct; 52(10):e65-73. PubMed ID: 23222531
[TBL] [Abstract][Full Text] [Related]
5. Information on chemotherapy and hormone therapy from tumor registry had moderate agreement with chart reviews.
Du XL; Key CR; Dickie L; Darling R; Delclos GL; Waller K; Zhang D
J Clin Epidemiol; 2006 Jan; 59(1):53-60. PubMed ID: 16360561
[TBL] [Abstract][Full Text] [Related]
6. Identifying incident colorectal and lung cancer cases in health service utilisation databases in Australia: a validation study.
Goldsbury D; Weber M; Yap S; Banks E; O'Connell DL; Canfell K
BMC Med Inform Decis Mak; 2017 Feb; 17(1):23. PubMed ID: 28241763
[TBL] [Abstract][Full Text] [Related]
7. The utility of Medicare claims data for measuring cancer stage.
Cooper GS; Yuan Z; Stange KC; Amini SB; Dennis LK; Rimm AA
Med Care; 1999 Jul; 37(7):706-11. PubMed ID: 10424641
[TBL] [Abstract][Full Text] [Related]
8. Comparing breast cancer case identification using HMO computerized diagnostic data and SEER data.
Rolnick SJ; Hart G; Barton MB; Herrinton L; Flores SK; Paulsen KJ; Husson G; Harris EL; Geiger AM; Elmore JG; Fletcher SW
Am J Manag Care; 2004 Apr; 10(4):257-62. PubMed ID: 15124502
[TBL] [Abstract][Full Text] [Related]
9. Identifying specific chemotherapeutic agents in Medicare data: a validation study.
Lund JL; Stürmer T; Harlan LC; Sanoff HK; Sandler RS; Brookhart MA; Warren JL
Med Care; 2013 May; 51(5):e27-34. PubMed ID: 22080337
[TBL] [Abstract][Full Text] [Related]
10. Utility of the SEER-Medicare data to identify chemotherapy use.
Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB
Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Unplanned Hospitalizations in Patients With Nonmetastatic Lung Cancer During Chemotherapy.
Fessele KL; Hayat MJ; Atkins RL
Oncol Nurs Forum; 2017 Sep; 44(5):E203-E212. PubMed ID: 28820513
[TBL] [Abstract][Full Text] [Related]
12. Area-level variations in cancer care and outcomes.
Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ
Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623
[TBL] [Abstract][Full Text] [Related]
13. Assessing Cancer Treatment Information Using Medicare and Hospital Discharge Data among Women with Non-Hodgkin Lymphoma in a Los Angeles County Case-Control Study.
Zhong C; Seibold P; Chao CR; Cozen W; Song JY; Weisenburger D; Bernstein L; Wang SS
Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):936-941. PubMed ID: 32066614
[TBL] [Abstract][Full Text] [Related]
14. Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees.
Riley GF; Potosky AL; Lubitz JD; Brown ML
Am J Public Health; 1994 Oct; 84(10):1598-604. PubMed ID: 7943477
[TBL] [Abstract][Full Text] [Related]
15. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
[TBL] [Abstract][Full Text] [Related]
16. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.
Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973
[TBL] [Abstract][Full Text] [Related]
17. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries.
Walker GV; Giordano SH; Williams M; Jiang J; Niu J; MacKinnon J; Anderson P; Wohler B; Sinclair AH; Boscoe FP; Schymura MJ; Buchholz TA; Smith BD
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):686-93. PubMed ID: 23773392
[TBL] [Abstract][Full Text] [Related]
18. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.
Riley GF; Potosky AL; Klabunde CN; Warren JL; Ballard-Barbash R
JAMA; 1999 Feb; 281(8):720-6. PubMed ID: 10052442
[TBL] [Abstract][Full Text] [Related]
19. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database.
Wang K; Sheets NC; Basak R; Chen RC
Cancer; 2016 Oct; 122(19):3069-74. PubMed ID: 27352280
[TBL] [Abstract][Full Text] [Related]
20. Revisiting the Surveillance Epidemiology and End Results Cancer Registry and Medicare Health Outcomes Survey (SEER-MHOS) Linked Data Resource for Patient-Reported Outcomes Research in Older Adults with Cancer.
Kent EE; Malinoff R; Rozjabek HM; Ambs A; Clauser SB; Topor MA; Yuan G; Burroughs J; Rodgers AB; DeMichele K
J Am Geriatr Soc; 2016 Jan; 64(1):186-92. PubMed ID: 26782871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
